Drugs / MCT/LCT/omega-3 (5:4:1)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00396461 | Nov 2006 → Sep 2010 | critical illness polyneuropathy | B. Braun Medical SA | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCT/LCT/omega-3 (5:4:1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00396461 ↗ |